247 related articles for article (PubMed ID: 29029103)
1. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.
Smit M; van Zoest RA; Nichols BE; Vaartjes I; Smit C; van der Valk M; van Sighem A; Wit FW; Hallett TB; Reiss P;
Clin Infect Dis; 2018 Feb; 66(5):743-750. PubMed ID: 29029103
[TBL] [Abstract][Full Text] [Related]
2. Future challenges for clinical care of an ageing population infected with HIV: a modelling study.
Smit M; Brinkman K; Geerlings S; Smit C; Thyagarajan K; Sighem Av; de Wolf F; Hallett TB;
Lancet Infect Dis; 2015 Jul; 15(7):810-8. PubMed ID: 26070969
[TBL] [Abstract][Full Text] [Related]
3. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.
Tripathi A; Liese AD; Winniford MD; Jerrell JM; Albrecht H; Rizvi AA; Zhang J; Duffus WA
Clin Cardiol; 2014 Sep; 37(9):517-22. PubMed ID: 25223811
[TBL] [Abstract][Full Text] [Related]
4. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
Stevens W; Peneva D; Li JZ; Liu LZ; Liu G; Gao R; Lakdawalla DN
BMC Health Serv Res; 2016 May; 16():175. PubMed ID: 27165638
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD).
Bijker R; Kumarasamy N; Kiertiburanakul S; Pujari S; Lam W; Chaiwarith R; Wong WW; Kamarulzaman A; Kantipong P; Avihingsanon A; Nguyen KV; Tanuma J; Ng OT; Sim BL; Merati TP; Choi JY; Ditangco R; Yunihastuti E; Sun LP; Do CD; Ross J; Law M;
Antivir Ther; 2019; 24(4):271-279. PubMed ID: 30833516
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk prediction in HIV-infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score (ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE-NL) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) risk prediction models.
Krikke M; Hoogeveen RC; Hoepelman AI; Visseren FL; Arends JE
HIV Med; 2016 Apr; 17(4):289-97. PubMed ID: 26268806
[TBL] [Abstract][Full Text] [Related]
7. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
[TBL] [Abstract][Full Text] [Related]
8. HIV infection, aging and cardiovascular disease: epidemiology and prevention.
Petoumenos K; Worm SW
Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031
[TBL] [Abstract][Full Text] [Related]
9. Severe infection increases cardiovascular risk among HIV-infected individuals.
Mesquita EC; Coelho LE; Amancio RT; Veloso V; Grinsztejn B; Luz P; Bozza FA
BMC Infect Dis; 2019 Apr; 19(1):319. PubMed ID: 30975092
[TBL] [Abstract][Full Text] [Related]
10. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.
Losina E; Hyle EP; Borre ED; Linas BP; Sax PE; Weinstein MC; Rusu C; Ciaranello AL; Walensky RP; Freedberg KA
Clin Infect Dis; 2017 Oct; 65(8):1266-1271. PubMed ID: 28605504
[TBL] [Abstract][Full Text] [Related]
11. Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
De Socio GV; Pucci G; Baldelli F; Schillaci G
BMC Infect Dis; 2017 Jun; 17(1):414. PubMed ID: 28606059
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease.
Guo F; Hsieh E; Lv W; Han Y; Xie J; Li Y; Song X; Li T
BMC Infect Dis; 2017 Apr; 17(1):287. PubMed ID: 28427339
[TBL] [Abstract][Full Text] [Related]
13. Intensive statin regimens for reducing risk of cardiovascular diseases among human immunodeficiency virus-infected population: A nation-wide longitudinal cohort study 2000-2011.
Ou HT; Chang KC; Li CY; Yang CY; Ko NY
Int J Cardiol; 2017 Mar; 230():592-598. PubMed ID: 28062146
[TBL] [Abstract][Full Text] [Related]
14. High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study.
Liu J; Hou Y; Sun L; Wang L; He Y; Zhou Y; Xu L; Liu X; Zhao F; Zhang L; Wang H; Wang FS
Emerg Microbes Infect; 2021 Dec; 10(1):416-423. PubMed ID: 33620297
[TBL] [Abstract][Full Text] [Related]
15. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease burden among human immunodeficiency virus-infected individuals.
Demir OM; Candilio L; Fuster D; Muga R; Barbaro G; Colombo A; Azzalini L
Int J Cardiol; 2018 Aug; 265():195-203. PubMed ID: 29885686
[TBL] [Abstract][Full Text] [Related]
17. Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?
Martin-Iguacel R; Llibre JM; Friis-Moller N
Curr HIV/AIDS Rep; 2015 Dec; 12(4):375-87. PubMed ID: 26423407
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.
Esser S; Gelbrich G; Brockmeyer N; Goehler A; Schadendorf D; Erbel R; Neumann T; Reinsch N
Clin Res Cardiol; 2013 Mar; 102(3):203-13. PubMed ID: 23117698
[TBL] [Abstract][Full Text] [Related]
19. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
20. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
